Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.

Genes and immunity - 1 Feb 2001

Howell W M, Turner S J, Bateman A C, Theaker J M

Abstract excerpt

Cutaneous malignant melanoma (CMM) is the most serious cutaneous malignancy. CMM patients often develop an immune response to their tumours. Conflicting evidence suggests that IL-10 may contribute to tumour escape from the immune response, but may also have an anti-tumour effect. To distinguish b...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to DNA Primers
Share to Interleukin-10

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Polymerase Chain Reaction

Share to Polymorphism, Single Nucleotide

Share to Promoter Regions, Genetic

Share to Skin Neoplasms

Source

Identifiers

PMID: 11294564
DOI: 10.1038/sj.gene.6363726

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-11294564-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.PMID 11294564Read ↗

Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease.Semantic proximity Read ↗

Interleukin-10, interleukin-6 and interferon-gamma gene polymorphisms in melanoma patients.Semantic proximity Read ↗

Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma.Semantic proximity Read ↗

The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma.Semantic proximity Read ↗

Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.Semantic proximity Read ↗

Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case--control study.Semantic proximity Read ↗

Cytokine gene polymorphisms, cancer susceptibility, and prognosis.Semantic proximity Read ↗

Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population.Semantic proximity Read ↗

Interleukin-10 polymorphisms, cancer susceptibility and prognosis.Semantic proximity Read ↗

Involvement of interleukin-10 promoter polymorphisms in nonmelanoma skin cancers-a case study in non-Caucasian skin cancer patients.Semantic proximity Read ↗

ICAM-1 polymorphisms and development of cutaneous malignant melanoma.Semantic proximity Read ↗

Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.